Cytohesins Are Cytoplasmic ErbB Receptor Activators

Cell

Volumn 143, Issue 2, 2010, Pages 201-211

  Bill, Anke ^a   Schmitz, Anton ^a   Albertoni, Barbara ^a   Song, Jin Na ^a   Heukamp, Lukas C ^b   Walrafen, David ^a   Thorwirth, Franziska ^c   Verveer, Peter J ^c   Zimmer, Sebastian ^b   Meffert, Lisa ^b   Schreiber, Arne ^a   Chatterjee, Sampurna ^d   Thomas, Roman K ^d,e,f   Ullrich, Roland T ^d   Lang, Thorsten ^a   Famulok, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e CHEMICAL GENOMICS CENTRE OF THE MAX PLANCK SOCIETY   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Humdisease; Signaling

Indexed keywords

CYTOHESIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; CYTOHESIN-1; CYTOHESIN-2; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; PROTEIN TYROSINE KINASE; SECINH3; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR XENOGRAFT; ADENOCARCINOMA; ANIMAL; ANTAGONISTS AND INHIBITORS; CANCER TRANSPLANTATION; DIMERIZATION; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; DIMERIZATION; GENE KNOCKDOWN TECHNIQUES; GTPASE-ACTIVATING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LUNG NEOPLASMS; MICE; NEOPLASM TRANSPLANTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; TRIAZOLES;

EID: 77957799869     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.09.011     Document Type: Article

References (53)

1. Abulrob A., Lu Z., Baumann E., Vobornik D., Taylor R., Stanimirovic D., Johnston L.J. Nanoscale imaging of epidermal growth factor receptor clustering. J. Biol. Chem. 2010, 285:3145-3156.
2. Anastasi S., Baietti M.F., Frosi Y., Alema S., Segatto O. The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity. Oncogene 2007, 26:7833-7846.
3. Bergamin E., Hallock P.T., Burden S.J., Hubbard S.R. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization. Mol. Cell 2010, 39:100-109.
4. Bi X., Schmitz A., Hayallah A.M., Song J.N., Famulok M. Affinity-based labeling of cytohesins with a bifunctional SecinH3 photoaffinity probe. Angew. Chem. Int. Ed. Engl. 2008, 47:9565-9568.
5. Bos J.L., Rehmann H., Wittinghofer A. GEFs and GAPs: Critical elements in the control of small G proteins. Cell 2007, 129:865-877.
6. Bose R., Zhang X. The ErbB kinase domain: Structural perspectives into kinase activation and inhibition. Exp. Cell Res. 2009, 315:649-658.
7. Brambilla E., Travis W.D., Colby T.V., Corrin B., Shimosato Y. The new World Health Organization classification of lung tumours. Eur. Respir. J. 2001, 18:1059-1068.
8. Bublil E.M., Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr. Opin. Cell Biol. 2007, 19:124-134.
9. Casanova J.E. Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 2007, 8:1476-1485.
10. Cherfils J., Menetrey J., Mathieu M., Le Bras G., Robineau S., Beraud-Dufour S., Antonny B., Chardin P. Structure of the Sec7 domain of the Arf exchange factor ARNO. Nature 1998, 392:101-105.
11. Chung I., Akita R., Vandlen R., Toomre D., Schlessinger J., Mellman I. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 2010, 464:783-787.
12. Cui T.-X., Nakagami H., Nahmias C., Shiuchi T., Takeda-Matsubara Y., Li J.-M., Wu L., Iwai M., Horiuchi M. Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells. Mol. Endocrinol. 2002, 16:2113-2123.
13. D'Souza-Schorey C., Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 2006, 7:347-358.
14. Ferby I., Reschke M., Kudlacek O., Knyazev P., Pante G., Amann K., Sommergruber W., Kraut N., Ullrich A., Fassler R., Klein R. Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation. Nat. Med. 2006, 12:568-573.
15. Ferguson K.M. Structure-based view of epidermal growth factor receptor regulation. Annu. Rev. Biophys. 2008, 37:353-373.
16. Fischer O.M., Hart S., Gschwind A., Ullrich A. EGFR signal transactivation in cancer cells. Biochem. Soc. Trans. 2003, 31:1203-1208.
17. Friedrichs N., Steiner S., Buettner R., Knoepfle G. Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast. Histopathology 2007, 51:814-823.
18. Gadella T.W., Jovin T.M. Oligomerization of epidermal growth factor receptors on A431 cells studied by time-resolved fluorescence imaging microscopy. A stereochemical model for tyrosine kinase receptor activation. J. Cell Biol. 1995, 129:1543-1558.
19. Gazdar A.F. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene 2009, 28:S24-S31.
20. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983, 31:13-20.
21. Hafner M., Schmitz A., Grune I., Srivatsan S.G., Paul B., Kolanus W., Quast T., Kremmer E., Bauer I., Famulok M. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 2006, 444:941-944.
22. Hell S.W., Wichmann J. Breaking the diffraction resolution limit by stimulated emission: stimulated-emission-depletion fluorescence microscopy. Opt. Lett. 1994, 19:780-782.
23. Heukamp L.C., Fischer H.P., Schirmacher P., Chen X., Breuhahn K., Nicolay C., Buttner R., Gutgemann I. Podocalyxin-like protein 1 expression in primary hepatic tumours and tumour-like lesions. Histopathology 2006, 49:242-247.
24. Inoue A., Setoguchi K., Matsubara Y., Okada K., Sato N., Iwakura Y., Higuchi O., Yamanashi Y. Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. Sci. Signal. 2009, 2:ra7.
25. Jura N., Endres N.F., Engel K., Deindl S., Das R., Lamers M.H., Wemmer D.E., Zhang X., Kuriyan J. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 2009, 137:1293-1307.
26. Kolanus W. Guanine nucleotide exchange factors of the cytohesin family and their roles in signal transduction. Immunol. Rev. 2007, 218:102-113.
27. Lang T., Bruns D., Wenzel D., Riedel D., Holroyd P., Thiele C., Jahn R. SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J. 2001, 20:2202-2213.
28. Lim J., Zhou M., Veenstra T.D., Morrison D.K. The CNK1 scaffold binds cytohesins and promotes insulin pathway signaling. Genes Dev. 2010, 24:1496-1506.
29. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., Harris P.L., Haserlat S.M., Supko J.G., Haluska F.G., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N. Engl. J. Med. 2004, 350:2129-2139.
30. Mayer G., Blind M., Nagel W., Bohm T., Knorr T., Jackson C.L., Kolanus W., Famulok M. Controlling small guanine-nucleotide-exchange factor function through cytoplasmic RNA intramers. Proc. Natl. Acad. Sci. USA 2001, 98:4961-4965.
31. Mi L.-Z., Grey M.J., Nishida N., Walz T., Lu C., Springer T.A. Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs. Biochemistry 2008, 47:10314-10323.
32. Moriki T., Maruyama H., Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 2001, 311:1011-1026.
33. Nagy P., Jenei A., Kirsch A.K., Szollosi J., Damjanovich S., Jovin T.M. Activation-dependent clustering of the erbB2 receptor tyrosine kinase detected by scanning near-field optical microscopy. J. Cell Sci. 1999, 112:1733-1741.
34. Paez J.G., Janne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., Herman P., Kaye F.J., Lindeman N., Boggon T.J., et al. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
35. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., Singh B., Heelan R., Rusch V., Fulton L., et al. EGF receptor gene mutations are common in lung cancers from " never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc. Natl. Acad. Sci. USA 2004, 101:13306-13311.
36. Qiu C., Tarrant M.K., Choi S.H., Sathyamurthy A., Bose R., Banjade S., Pal A., Bornmann W.G., Lemmon M.A., Cole P.A., Leahy D.J. Mechanism of activation and inhibition of the HER4/ErbB4 kinase. Structure 2008, 16:460-467.
37. Qiu C., Tarrant M.K., Boronina T., Longo P.A., Kavran J.M., Cole R.N., Cole P.A., Leahy D.J. In vitro enzymatic characterization of near full length EGFR in activated and inhibited states. Biochemistry 2009, 48:6624-6632.
38. Red Brewer M., Choi S.H., Alvarado D., Moravcevic K., Pozzi A., Lemmon M.A., Carpenter G. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 2009, 34:641-651.
39. Reschke M., Ferby I., Stepniak E., Seitzer N., Horst D., Wagner E.F., Ullrich A. Mitogen-inducible gene-6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma. Hepatology 2009, 51:1383-1390.
40. Sharma S.V., Settleman J. ErbBs in lung cancer. Exp. Cell Res. 2009, 315:557-571.
41. Sharma S.V., Bell D.W., Settleman J., Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Mol. Cell Biol. 2007, 7:169-181.
42. Shields A.F., Grierson J.R., Dohmen B.M., Machulla H.J., Stayanoff J.C., Lawhorn-Crews J.M., Obradovich J.E., Muzik O., Mangner T.J. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat. Med. 1998, 4:1334-1336.
43. Sorkin A., Goh L.K. Endocytosis and intracellular trafficking of ErbBs. Exp. Cell Res. 2008, 315:683-696.
44. Squire A., Verveer P.J., Rocks O., Bastiaens P.I.H. Red-edge anisotropy microscopy enables dynamic imaging of homo-FRET between green fluorescent proteins in cells. J. Struct. Biol. 2004, 147:62-69.
45. Stuhlmann-Laeisz C., Lang S., Chalaris A., Krzysztof P., Enge S., Eichler J., Klingmuller U., Samuel M., Ernst M., Rose-John S., Scheller J. Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells. Mol. Biol. Cell 2006, 17:2986-2995.
46. Vilar M., Charalampopoulos I., Kenchappa R.S., Simi A., Karaca E., Reversi A., Choi S., Bothwell M., Mingarro I., Friedman W.J., et al. Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 2009, 62:72-83.
47. Wang Q., Villeneuve G., Wang Z. Control of epidermal growth factor receptor endocytosis by receptor dimerization, rather than receptor kinase activation. EMBO Rep. 2005, 6:942-948.
48. Weinstein I.B. Addiction to oncogenes-the Achilles heal of cancer. Science 2002, 297:63-64.
49. Yarden Y., Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 1987, 26:1434-1442.
50. Zhang X., Gureasko J., Shen K., Cole P.A., Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006, 125:1137-1149.
51. Zhang X., Pickin K.A., Bose R., Jura N., Cole P.A., Kuriyan J. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature 2007, 450:741-744.
52. Zhu H.J., Iaria J., Orchard S., Walker F., Burgess A.W. Epidermal growth factor receptor: association of extracellular domain negatively regulates intracellular kinase activation in the absence of ligand. Growth Factors 2003, 21:15-30.
53. Zimmer S., Kahl P., Buhl T.M., Steiner S., Wardelmann E., Merkelbach-Bruse S., Buettner R., Heukamp L.C. Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling. J. Cancer Res. Clin. Oncol. 2008, 135:723-730.